World's Best Scientists 2026 revealed!
Andreas Hombach

Andreas Hombach

D-Index & Metrics

Biology and Biochemistry

D-Index
53
Citations
9011
World Ranking
16279
National Ranking
1143

Overview

Andreas Hombach is affiliated with the University of Cologne in Germany and has contributed extensively to research in medicine, immunology, and biochemistry with a focus on oncology, immunology, and molecular biology. Their research centers primarily on CAR-T cell therapy and immune cell function.

The scientist's publication record includes notable papers such as:

  • IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells, 2020, Cells
  • IL12 integrated into the CAR exodomain converts CD8+ T cells to poly-functional NK-like cells with superior killing of antigen-loss tumors, 2021, Molecular Therapy
  • CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation, 2023, Frontiers in Immunology
  • Anti-CD19 CAR T cells potently redirected to kill solid tumor cells, 2021, PLoS ONE
  • Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function, 2024, Journal for ImmunoTherapy of Cancer

Frequent co-authors include:

  • Hinrich Abken
  • Markus Barden
  • Christine Ambrose
  • Roy R. Lobb
  • Paul D. Rennert

The main fields of study covered are:

  • Medicine
  • Immunology and Microbiology
  • Biochemistry, Genetics and Molecular Biology

The more specific subfields explored in their work encompass:

  • Oncology
  • Immunology
  • Genetics
  • Molecular Biology
  • Biomedical Engineering

Research topics prominently featured include:

  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Virus-based gene therapy research
  • Viral Infectious Diseases and Gene Expression in Insects
  • Mesenchymal stem cell research
  • Nanowire Synthesis and Applications

Best Publications

  • Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.

    Andreas Hombach;Anja Wieczarkowiecz;Thomas Marquardt;Claudia Heuser

  • T Cell Activation by Antibody-Like Immunoreceptors: Increase in Affinity of the Single-Chain Fragment Domain above Threshold Does Not Increase T Cell Activation against Antigen-Positive Target Cells but Decreases Selectivity

    Markus Chmielewski;Andreas Hombach;Claudia Heuser;Gregory P. Adams

  • Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc 'spacer' domain in the extracellular moiety of chimeric antigen receptors avoids 'off-target' activation and unintended initiation of an innate immune response.

    A Hombach;A A Hombach;H Abken

  • Epstein Barr virus–specific cytotoxic T lymphocytes expressing the anti-CD30ζ artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease

    Barbara Savoldo;Cliona M. Rooney;Cliona M. Rooney;Antonio Di Stasi;Hinrich Abken

  • Chronic inflammatory bowel disease and cancer

    C Pohl;A Hombach;W Kruis

  • Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells.

    Markus Chmielewski;Andreas A. Hombach;Hinrich Abken

  • T cells that target carcinoembryonic antigen eradicate orthotopic pancreatic carcinomas without inducing autoimmune colitis in mice.

    Markus Chmielewski;Olga Hahn;Gunter Rappl;Michael Nowak

  • T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.

    Andreas Hombach;Dagmar Sent;Claudia Schneider;Claudia Heuser

  • Eradication of melanomas by targeted elimination of a minor subset of tumor cells

    Patrick Schmidt;Caroline Kopecky;Andreas Hombach;Paola Zigrino

  • Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer

    K Birkholz;A Hombach;C Krug;S Reuter

  • Chimeric Antigen Receptors for T-Cell Based Therapy

    Eleanor J. Cheadle;Vicky Sheard;Andreas A. Hombach;Markus Chmielewski

  • Building Better Chimeric Antigen Receptors for Adoptive T Cell Therapy

    John S. Bridgeman;Robert E. Hawkins;Andreas A. Hombach;Hinrich Abken

  • Rational development of high-affinity T-cell receptor-like antibodies

    Guillaume Stewart-Jones;Andreas Wadle;Anja Hombach;Eugene Shenderov

  • A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA.

    A Hombach;D Koch;R Sircar;C Heuser

  • Arming Cytokine-induced Killer Cells With Chimeric Antigen Receptors: CD28 Outperforms Combined CD28–OX40 “Super-stimulation”

    Andreas A Hombach;Gunter Rappl;Hinrich Abken

  • An anti-CD30 chimeric receptor that mediates CD3-zeta-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30.

    Andreas Hombach;Claudia Heuser;Ranjan Sircar;Thorsten Tillmann

  • T Cell Activation by Antibody-Like Immunoreceptors: The Position of the Binding Epitope within the Target Molecule Determines the Efficiency of Activation of Redirected T Cells

    Andreas A. Hombach;Verena Schildgen;Claudia Heuser;Ricarda Finnern

  • CD28 costimulation Impairs the efficacy of a redirected t-cell antitumor attack in the presence of regulatory t cells which can be overcome by preventing Lck activation.

    David M Kofler;Markus Chmielewski;Gunter Rappl;Anja Hombach

  • Tuning tumor-specific T-cell activation: a matter of costimulation?

    Hinrich Abken;Andreas Hombach;Claudia Heuser;Kai Kronfeld

  • CD28 Costimulation Overcomes Transforming Growth Factor-β–Mediated Repression of Proliferation of Redirected Human CD4+ and CD8+ T Cells in an Antitumor Cell Attack

    Heike Koehler;David Kofler;Andreas Hombach;Hinrich Abken

Frequent Co-Authors

Hinrich Abken
Hinrich Abken University of Regensburg
Volker Diehl
Volker Diehl University of Cologne
Alexander Knuth
Alexander Knuth University of Zurich
Vincenzo Cerundolo
Vincenzo Cerundolo University of Oxford
Andrew J. McMichael
Andrew J. McMichael University of Oxford
Malcolm K. Brenner
Malcolm K. Brenner Baylor College of Medicine
Gianpietro Dotti
Gianpietro Dotti University of North Carolina at Chapel Hill
Soldano Ferrone
Soldano Ferrone Harvard University
Helen E. Heslop
Helen E. Heslop Baylor College of Medicine
Cliona M. Rooney
Cliona M. Rooney Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens doors to multiple healthcare career options that can be further advanced with specialized online degrees. Many students look into continuing education to increase their qualifications or shift into new clinical roles. For example, online fnp programs offer a streamlined path for registered nurses aiming to become Family Nurse Practitioners, greatly expanding their clinical scope.

If you are interested in nutrition, accredited online dietetics programs provide affordable ways to qualify as a registered dietitian or nutritionist. Nurses who want to progress in their field without pausing their careers might pursue online rn to bsn programs, which can be completed flexibly and efficiently.

Those with a passion for leadership may consider a masters degree in healthcare management, unlocking opportunities in administration and management within healthcare systems. With these online options, students and professionals can balance work, life, and advanced study—making career advancement more accessible than ever.

Best Scientists Citing Andreas Hombach

Trending Scientists

Recently Published Articles